Acetylleucine
Product Specifications
UNSPSC Description
Acetylleucine (N-Acetyl-DL-leucine), orally active compound, can be used for the research of acute vestibular vertigo, cerebellar ataxia and nystagmus[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Acetylleucine.html
Purity
99.38
Solubility
DMSO : 120 mg/mL (ultrasonic)|H2O : 6.67 mg/mL (ultrasonic)
Smiles
CC(C)CC(C(O)=O)NC(C)=O
Molecular Weight
173.212
References & Citations
[1]Feil K, et, al. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus. Cerebellum. 2016 Feb;15(1):38-42.|[2]Clément G, et, al. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical. J Vestib Res. 2007;17(5-6):227-37.|[3]Günther L, et al. N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamus. PLoS One. 2015 Mar 24;10(3):e0120891.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B1442/Acetylleucine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B1442/Acetylleucine-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
99-15-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
